Biome Australia Ltd
Biome Australia Limited is an Australia-based microbiome health company.
The business
Biome Australia Limited is an Australia-based microbiome health company. The Company develops, licenses, commercializes and markets evidence-based live biotherapeutics (probiotics) and complementary medicines. It develops, manufactures, and distributes evidence-based products linking the gut and human health through the Company owned brands, such as Activated Nutrients and Activated Probiotics. Activated Nutrients offers a range of completely organic, plant-based, all in-one nutritional products. Activated Probiotics offers a range of clinically backed precision probiotics. Activated Probiotics provides live biotherapeutic products clinically proven to help prevent and support the management of various health concerns, including low mood and sleep, bone health, iron malabsorption, mild eczema and irritable bowel syndrome. Activated Probiotics products include Biome Acne Probiotic, Biome Baby Probiotic, Biome Eczema Probiotic, Biome Her Probiotic, among others.
Share price
Market Statistics
Valuation
Trading Activity
Performance
Latest news
Biome Australia Expands Retail Distribution with Mecca and Go Vita Partnerships
Biome Australia (ASX: BIO) has struck new distribution agreements with Mecca and Go Vita, marking a significant expansion for its flagship Activated Probiotics range into both premium beauty and mainstream health food retail. The company said the partnerships represent a turning point in its distribution strategy, extending reach into high-traffic retail environments while reinforcing its […]
Market wrap: Australia ignores Wall Street record on faltering miners
The Australian share market once again ignored a rally on Wall Street to a fresh record high and closed down 0.3% thanks to a broad-based slump on Friday. It was yet another reminder of how the Australian bourse with its heavy concentration of miners and banks has disconnected from the Artificial Intelligence rally that is […]
Biome Australia expects to surpass FY24 earnings guidance on back of record sales revenue
Biome Australia (ASX: BIO) is on target to easily beat its 2024 financial year forecast after a strong period of revenue. The microbiome health specialist had predicted FY2024 earnings of $12.5 million but record sales numbers for April and May have increased expectations. This follows the company’s initial $11.5m estimate announced in October 2023 being […]
Market wrap: ASX 200 dips slightly despite energy rally
Despite a continuing rally for energy stocks on the back of a rising oil price, the Australian share market fell a little lower, following a volatile day on Wall Street. The energy sector was up 0.5% following rising oil prices which spiked to US$79 a barrel after the US and UK launched airstrikes on Houthi […]
Looking for charts & signals? See the tab.
Unlock the full research library - free.
Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.